Conflicts of interest. IOM panel backs public disclosure of drug company payments.
Kaiser
Jocelyn
J
D016265:Conflict of Interest; D030881:Disclosure; D004345:Drug Industry / Q000191:economics / Q000941:ethics*; D005180:Faculty, Medical; D006801:Humans; D015969:National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; D012108:Research Personnel / Q000191:economics / Q000941:ethics*; D014481:United States